Kelly Shi
Stock Analyst at Jefferies
(3.14)
# 1,064
Out of 5,154 analysts
34
Total ratings
42.42%
Success rate
16.88%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Kelly Shi
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IBRX ImmunityBio | Maintains: Buy | $8 → $9 | $8.67 | +3.81% | 2 | Dec 12, 2025 | |
| KYMR Kymera Therapeutics | Maintains: Buy | $73 → $122 | $83.49 | +46.13% | 2 | Dec 9, 2025 | |
| PTCT PTC Therapeutics | Maintains: Buy | $63 → $77 | $62.82 | +22.57% | 4 | Oct 28, 2025 | |
| INSM Insmed | Maintains: Buy | $129 → $148 | $140.13 | +5.62% | 2 | Aug 13, 2025 | |
| COGT Cogent Biosciences | Maintains: Buy | $23 → $28 | $37.08 | -24.49% | 1 | Jul 7, 2025 | |
| SMMT Summit Therapeutics | Maintains: Buy | $31 → $44 | $15.11 | +191.20% | 1 | Apr 25, 2025 | |
| VSTM Verastem | Initiates: Buy | $15 | $6.38 | +135.11% | 1 | Apr 10, 2025 | |
| TIL Instil Bio | Upgrades: Buy | $11 → $52 | $8.87 | +486.25% | 2 | Jan 7, 2025 | |
| FHTX Foghorn Therapeutics | Maintains: Buy | $18 → $14 | $5.78 | +142.21% | 2 | Dec 16, 2024 | |
| CNTA Centessa Pharmaceuticals | Maintains: Buy | $13 → $19 | $25.95 | -26.78% | 2 | Sep 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $174 → $196 | $240.65 | -18.55% | 2 | Aug 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $21 | $5.74 | +265.85% | 1 | Aug 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $37 | $22.07 | +67.65% | 1 | Jun 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $6 | $2.30 | +160.87% | 2 | Jun 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $81 | $95.94 | -15.57% | 1 | Feb 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $35 | $23.43 | +49.38% | 1 | Feb 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $36 | $3.17 | +1,035.65% | 1 | Feb 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $16 | $18.15 | -11.85% | 1 | Nov 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $20 | $17.80 | +12.36% | 1 | Aug 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $432 | $7.29 | +5,825.93% | 1 | Mar 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $52 | $13.85 | +275.45% | 1 | Aug 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $27 | $2.48 | +988.71% | 1 | Apr 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $33 | $2.84 | +1,061.97% | 1 | Mar 8, 2021 |
ImmunityBio
Dec 12, 2025
Maintains: Buy
Price Target: $8 → $9
Current: $8.67
Upside: +3.81%
Kymera Therapeutics
Dec 9, 2025
Maintains: Buy
Price Target: $73 → $122
Current: $83.49
Upside: +46.13%
PTC Therapeutics
Oct 28, 2025
Maintains: Buy
Price Target: $63 → $77
Current: $62.82
Upside: +22.57%
Insmed
Aug 13, 2025
Maintains: Buy
Price Target: $129 → $148
Current: $140.13
Upside: +5.62%
Cogent Biosciences
Jul 7, 2025
Maintains: Buy
Price Target: $23 → $28
Current: $37.08
Upside: -24.49%
Summit Therapeutics
Apr 25, 2025
Maintains: Buy
Price Target: $31 → $44
Current: $15.11
Upside: +191.20%
Verastem
Apr 10, 2025
Initiates: Buy
Price Target: $15
Current: $6.38
Upside: +135.11%
Instil Bio
Jan 7, 2025
Upgrades: Buy
Price Target: $11 → $52
Current: $8.87
Upside: +486.25%
Foghorn Therapeutics
Dec 16, 2024
Maintains: Buy
Price Target: $18 → $14
Current: $5.78
Upside: +142.21%
Centessa Pharmaceuticals
Sep 11, 2024
Maintains: Buy
Price Target: $13 → $19
Current: $25.95
Upside: -26.78%
Aug 13, 2024
Maintains: Buy
Price Target: $174 → $196
Current: $240.65
Upside: -18.55%
Aug 13, 2024
Initiates: Buy
Price Target: $21
Current: $5.74
Upside: +265.85%
Jun 28, 2024
Initiates: Buy
Price Target: $37
Current: $22.07
Upside: +67.65%
Jun 10, 2024
Maintains: Buy
Price Target: $15 → $6
Current: $2.30
Upside: +160.87%
Feb 23, 2024
Initiates: Buy
Price Target: $81
Current: $95.94
Upside: -15.57%
Feb 20, 2024
Initiates: Buy
Price Target: $35
Current: $23.43
Upside: +49.38%
Feb 5, 2024
Initiates: Buy
Price Target: $36
Current: $3.17
Upside: +1,035.65%
Nov 11, 2022
Initiates: Buy
Price Target: $16
Current: $18.15
Upside: -11.85%
Aug 15, 2022
Initiates: Buy
Price Target: $20
Current: $17.80
Upside: +12.36%
Mar 4, 2022
Initiates: Buy
Price Target: $432
Current: $7.29
Upside: +5,825.93%
Aug 3, 2021
Initiates: Buy
Price Target: $52
Current: $13.85
Upside: +275.45%
Apr 13, 2021
Initiates: Buy
Price Target: $27
Current: $2.48
Upside: +988.71%
Mar 8, 2021
Initiates: Buy
Price Target: $33
Current: $2.84
Upside: +1,061.97%